154 related articles for article (PubMed ID: 12015168)
1. Cardio-facio-cutaneous syndrome and moyamoya syndrome.
Ishiguro Y; Kubota T; Takenaka J; Maruyama K; Okumura A; Negoro T; Watanabe K
Brain Dev; 2002 Jun; 24(4):245-9. PubMed ID: 12015168
[TBL] [Abstract][Full Text] [Related]
2. Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome.
Al-Rahawan MM; Chute DJ; Sol-Church K; Gripp KW; Stabley DL; McDaniel NL; Wilson WG; Waldron PE
Am J Med Genet A; 2007 Jul; 143A(13):1481-8. PubMed ID: 17567882
[TBL] [Abstract][Full Text] [Related]
3. Costello syndrome showing moyamoya-like vasculopathy.
Shiihara T; Kato M; Mitsuhashi Y; Hayasaka K
Pediatr Neurol; 2005 May; 32(5):361-3. PubMed ID: 15866441
[TBL] [Abstract][Full Text] [Related]
4. [A case of Turner's syndrome associated with moyamoya disease].
Ajimi Y; Uchida K; Kawase T; Toya S
No Shinkei Geka; 1992 Sep; 20(9):1021-4. PubMed ID: 1407355
[TBL] [Abstract][Full Text] [Related]
5. The cardio-facio-cutaneous syndrome: report of a patient and review of the literature.
Bottani A; Hammerer I; Schinzel A
Eur J Pediatr; 1991 May; 150(7):486-8. PubMed ID: 1915501
[TBL] [Abstract][Full Text] [Related]
6. Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease.
Reid AJ; Bhattacharjee MB; Regalado ES; Milewicz AL; El-Hakam LM; Dauser RC; Milewicz DM
J Neurosurg Pediatr; 2010 Sep; 6(3):244-9. PubMed ID: 20809708
[TBL] [Abstract][Full Text] [Related]
7. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome.
Sharfstein SR; Ahmed S; Islam MQ; Najjar MI; Ratushny V
J Stroke Cerebrovasc Dis; 2007; 16(6):268-72. PubMed ID: 18035245
[TBL] [Abstract][Full Text] [Related]
8. Cardio-facio-cutaneous (CFC) syndrome: report of two patients without hyperkeratotic skin lesions.
Matsuda Y; Murano I; Kondoh O; Matsuo K; Kajii T
Am J Med Genet; 1991 May; 39(2):144-7. PubMed ID: 1842204
[TBL] [Abstract][Full Text] [Related]
9. Additional patient with del(12)(q21.2q22): further evidence for a candidate region for cardio-facio-cutaneous syndrome?
Rauen KA; Albertson DG; Pinkel D; Cotter PD
Am J Med Genet; 2002 Jun; 110(1):51-6. PubMed ID: 12116271
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus associated with moyamoya syndrome.
El Ramahi KM; Al Rayes HM
Lupus; 2000; 9(8):632-6. PubMed ID: 11035439
[TBL] [Abstract][Full Text] [Related]
11. [Three Cases of Moyamoya Disease with a History of Kawasaki Disease].
Kawasaki T; Arakawa Y; Sugino T; Mitsuhara T; Funaki T; Kikuchi T; Koyanagi M; Yoshida K; Kunieda T; Takahashi JC; Takagi Y; Miyamoto S
No Shinkei Geka; 2015 Nov; 43(11):1005-10. PubMed ID: 26549721
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Moyamoya Disease and Unruptured Intracranial Aneurysm in Floating-Harbor Syndrome.
Coughlin DJ; Miller CA; Schuette AJ
World Neurosurg; 2017 Aug; 104():1049.e1-1049.e6. PubMed ID: 28549641
[TBL] [Abstract][Full Text] [Related]
13. Ocular malformations, moyamoya disease, and midline cranial defects: a distinct syndrome.
Bakri SJ; Siker D; Masaryk T; Luciano MG; Traboulsi EI
Am J Ophthalmol; 1999 Mar; 127(3):356-7. PubMed ID: 10088755
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous chylothorax in a case of cardio-facio-cutaneous syndrome.
Chan PC; Chiu HC; Hwu WL
Clin Dysmorphol; 2002 Oct; 11(4):297-8. PubMed ID: 12401999
[TBL] [Abstract][Full Text] [Related]
15. Retinitis pigmentosa in a young man with Noonan syndrome: further evidence that Noonan syndrome (NS) and the cardio-facio-cutaneous syndrome (CFC) are variable manifestations of the same entity?
Lorenzetti ME; Fryns JP
Am J Med Genet; 1996 Oct; 65(2):97-9. PubMed ID: 8911596
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome associated with systemic lupus erythematosus.
Jeong HC; Kim YJ; Yoon W; Joo SP; Lee SS; Park YW
Lupus; 2008 Jul; 17(7):679-82. PubMed ID: 18625642
[TBL] [Abstract][Full Text] [Related]
17. [A case of adult moyamoya disease showing fulminant clinical course associated with progression from unilateral to bilateral involvement].
Fujiwara F; Yamada H; Hayashi S; Tamaki N
No Shinkei Geka; 1997 Jan; 25(1):79-84. PubMed ID: 8990473
[TBL] [Abstract][Full Text] [Related]
18. [Systemic vascular change associated with moyamoya-like cerebrovascular disease and microvascular coronary artery disease].
Tokunaga Y; Toyoda K; Ago T; Ibayashi S; Usui M; Fujishima M
Rinsho Shinkeigaku; 1996 Feb; 36(2):318-22. PubMed ID: 8752687
[TBL] [Abstract][Full Text] [Related]
19. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome.
Yamashita Y; Kusaga A; Koga Y; Nagamitsu S; Matsuishi T
Pediatr Neurol; 2004 Nov; 31(5):364-6. PubMed ID: 15519121
[TBL] [Abstract][Full Text] [Related]
20. [An adult case of moyamoya disease associated with marked advance of occlusive lesion in the bilateral carotid system].
Aoki N; Kagawa M; Wanifuchi H; Takeshita M; Izawa M; Kitamura K
No Shinkei Geka; 1989 Apr; 17(4):399-403. PubMed ID: 2770977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
